移动应用作为慢性耳鸣数字疗法:一项随机临床试验
该双盲假对照随机临床试验纳入60例轻至重度慢性耳鸣患者,评估提供教育咨询与认知行为疗法元素的数字治疗App的疗效与安全性。16周时治疗组耳鸣残疾量表(THI)改善显著优于假对照组,组间变化差异为-20.4(95%CI,-28.2至-12.6),疗效维持至第24周。
要点
- 治疗App组第16周THI较假对照组显著改善,组间差异-20.4(95%CI,-28.2至-12.6)。
- 疗效维持至第24周,组间平均差异-18.3(95%CI,-26.4至-10.1)。
- 假对照组1例耳鸣加重,未见严重不良事件或设备故障。
核心结论
- 治疗App可显著且持久改善慢性耳鸣相关困扰与功能损害。
- 该App可能作为慢性耳鸣的有效标准化干预。
研究设计与样本
- 双盲、假对照随机临床试验,2023年9月至2025年2月进行。
- 纳入60例轻至重度慢性耳鸣患者,治疗组与假对照组各30例。
- 治疗期16周,随后8周随访期阻断治疗功能。
- 中位(IQR)年龄58.5(52.0-64.0)岁,女性33例(55%)。
- 基线THI总体均值(SD)为41.3(16.9)。
主要发现
- 第16周治疗组THI改善显著优于假对照组,组间变化差异-20.4(95%CI,-28.2至-12.6)。
- 疗效维持至第24周,组间平均差异-18.3(95%CI,-26.4至-10.1)。
- 假对照组1例耳鸣加重。
- 未见严重不良事件或可能危害健康的设备故障。
关键数值与推荐
- 主要结局为基线至第16周THI评分变化。
- 次要结局包括THI、耳鸣功能指数、耳鸣响度与控制数字评定量表、医院焦虑抑郁量表、雅典失眠量表及患者总体改善印象。
临床怎么用
- 数字治疗App可作为慢性耳鸣的标准化干预选项,尤其适用于无法获取认知行为疗法与助听器治疗者。
- 治疗16周可显著改善耳鸣相关困扰与功能损害,疗效可维持至24周。
局限性
- 样本量60例,结论需更大样本验证。
- 随访期仅至第24周,长期疗效未明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Tinnitus is a highly prevalent condition that has no cure and can severely impair quality of life. Patients who receive cognitive behavioral therapy (CBT) and hearing aid therapy for chronic tinnitus accompanied by hearing loss have shown some improvement, but access to these interventions is limited. OBJECTIVE: To develop a prototype digital therapeutic mobile app that provides educational counseling and CBT elements for treating chronic tinnitus symptoms and test its efficacy and safety for 16 weeks in patients reporting distressing chronic tinnitus. DESIGN, SETTING, AND PARTICIPANTS: This double-blind, sham-controlled randomized clinical trial was conducted from September 2023 to February 2025 in individuals diagnosed with mild to severe chronic tinnitus. The trial included a 16-week treatment phase followed by an 8-week follow-up phase. Data were analyzed from February to March 2025. INTERVENTION: Participants used either the therapeutic app or a sham control app that lacked the therapeutic functions. During the 8-week follow-up, the app's therapeutic functions were blocked and only the app's recording function was available. MAIN OUTCOMES AND MEASURES: The primary outcome was change from baseline to week 16 in the Tinnitus Handicap Inventory (THI) score, an index of tinnitus-related distress and functional impairment. Secondary outcomes were patient-reported and included THI, Tinnitus Functional Index, tinnitus loudness and control numeric rating scales, Hospital Anxiety and Depression Scale, Athens Insomnia Scale, and Patient Global Impression of Improvement. RESULTS: A total of 60 participants (33 [55%] female; median [IQR] age, 58.5 [52.0-64.0] years) were assessed, including 30 participants in the therapeutic app group and 30 participants in the sham-control app group. The overall mean (SD) baseline THI was 41.3 (16.9). At week 16, the therapeutic app group showed significantly greater improvement in THI scores compared with the sham-control app group (between-group difference in change in THI, -20.4; 95% CI, -28.2 to -12.6). The therapeutic effect was maintained up to week 24 (mean between-group difference, -18.3; 95% CI, -26.4 to -10.1). Tinnitus worsened in 1 patient in the sham-control app group. No serious adverse events or device malfunctions with potential for health hazards were observed. CONCLUSIONS AND RELEVANCE: This randomized clinical trial found that use of a tinnitus therapeutic app resulted in substantial and lasting improvement in tinnitus-related distress and functional impairment. The therapeutic app may serve as an effective and standardized intervention for individuals with chronic tinnitus. TRIAL REGISTRATION: jrct.mhlw.go.jp Identifier: 032230359.
引用
- Wasano K, Kawasaki T, Goto F, et al. Mobile Application as a Digital Therapeutic for Chronic Tinnitus: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2026. PMID: 42096236. doi:10.1001/jamaoto.2026.0858
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。